Skip to main content
Celemics, Inc. logo

Celemics, Inc. — Investor Relations & Filings

Ticker · 331920 ISIN · KR7331920009 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2020-12-15 Regulatory Filings
Country KR South Korea
Listing KO 331920

About Celemics, Inc.

https://www.celemics.com/

Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain full financial statements or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-12-15 Korean
기타경영사항(자율공시)(신주인수권 행사 결과)
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the exercise of stock warrants (신주인수권 행사 결과) and the subsequent issuance of new shares. This falls under the category of capital changes or share issuance. Since it specifically details the issuance of new shares resulting from the exercise of warrants, it aligns best with the 'Share Issue/Capital Change' (SHA) category.
2020-11-24 Korean
기타경영사항(자율공시)(신주인수권 행사)
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from the company Celemix regarding the exercise of stock warrants (신주인수권 행사) by the lead underwriter (Daishin Securities). This involves the issuance of new shares resulting from the exercise of these warrants. According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2020-11-23 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as date, location, purpose, and contact information for an upcoming meeting with institutional investors. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure.
2020-11-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Celemics, Inc.' covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial information, business operations, capital structure, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details the share transactions (specifically a sale of shares) by an executive (Han Hyo-jun) of Celemics. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which falls under the 'Director's Dealing' category.
2020-11-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.